Author details

Full Name

Roland Martin

Affiliation

ORCID

Career Start Year

1988

Papers

341

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37196088	Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.		2023
35163583	Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology.	International Journal of Molecular Sciences	2022
36229189	B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.	Neurology: Neuroimmunology and NeuroInflammation	2022
36142860	Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.	International Journal of Molecular Sciences	2022
35476434	Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.	Sci Adv	2022
36322629	Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis.	Science Translational Medicine	2022
35185762	Characterization of Antigen-Induced CD4+ T-Cell Senescence in Multiple Sclerosis.	Frontiers in Neurology	2022
35069562	Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis.	Frontiers in Immunology	2021
33858848	HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.	J Immunother Cancer	2021
34006391	Multiple sclerosis: doubling down on MHC.	Trends in Genetics	2021
34271980	Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.	Genome Med	2021
33828551	Antigen-Specific Immune Tolerance in Multiple Sclerosis-Promising Approaches and How to Bring Them to Patients.	Frontiers in Immunology	2021
33824434	Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review.	Bone Marrow Transplantation	2021
33649179	Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS.	Neurology: Neuroimmunology and NeuroInflammation	2021
32949466	Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.	European Journal of Immunology	2021
34975899	NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.	Frontiers in Immunology	2021
34535569	T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis.	Neurology: Neuroimmunology and NeuroInflammation	2021
31237711	The 3A6-TCR/superagonist/HLA-DR2a complex shows similar interface and reduced flexibility compared to the complex with self-peptide.	Proteins: Structure, Function and Bioinformatics	2020
32008573	Human CD4 T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro.	Fluids and Barriers of the CNS	2020
31882398	Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15.	Neurology: Neuroimmunology and NeuroInflammation	2020
33091337	HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.	Cell	2020
32644211	Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome.	European Journal of Neurology	2020
32920791	When a T cell engages a B cell: novel insights in multiple sclerosis.	Swiss Medical Weekly	2020
32853453	Neurological manifestations of coronavirus infections - a systematic review.	Annals of Clinical and Translational Neurology	2020
30894449	Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis.	Neurology	2019
31839982	Is multiple sclerosis progression associated with the HLA-DR15 haplotype?	Multiple Sclerosis Journal - Experimental, Translational and Clinical	2019
31554671	Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS.	Neurology: Neuroimmunology and NeuroInflammation	2019
30015656	Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.	J Neuroophthalmol	2019
29961995	In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study.	J Sleep Res	2019
31024521	Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4 T Cells in Multiple Sclerosis.	Frontiers in Immunology	2019
31004050	MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.	Proc Natl Acad Sci U S A	2019
29248894	A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).	J Neurol Neurosurg Psychiatry	2018
30173916	Memory B Cells Activate Brain-Homing, Autoreactive CD4 T Cells in Multiple Sclerosis.	Cell	2018
30305453	GDP-l-fucose synthase is a CD4 T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis.	Science Translational Medicine	2018
30323342	Targeting fibrin in neurodegeneration.	Nature Immunology	2018
29259996	Phenotypic and functional complexity of brain-infiltrating T cells in Rasmussen encephalitis.	Neurology: Neuroimmunology and NeuroInflammation	2018
29616027	Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions.	Frontiers in Immunology	2018
29656736	Understanding risk of PML through multiple sclerosis.	Lancet Neurology, The	2018
28105588	Nogo-A Antibodies for Progressive Multiple Sclerosis.	CNS Drugs	2017
28646336	Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology.	Acta Neuropathologica	2017
28621766	Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.	Nature Reviews Neurology	2017
29120025	Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility?	Swiss Medical Weekly	2017
29073203	Dynamics and heterogeneity of brain damage in multiple sclerosis.	PLoS Comput Biol	2017
28178353	Cystatin F is a biomarker of prion pathogenesis in mice.	PLoS ONE	2017
27730274	[Progressive multifocal leukoencephalopathy].	Der Nervenarzt	2016
27250994	Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.	Stem Cells Dev	2016
26874214	Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.	Annals of Neurology	2016
27467894	Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.	European Journal of Immunology	2016
27116718	Immunology of Multiple Sclerosis.	Seminars in Neurology	2016
27648464	Restoring immune tolerance in neuromyelitis optica: Part II.	Neurol Neuroimmunol Neuroinflamm	2016